January 1, 2022

Carvacrol preserves antioxidant status and attenuates kidney fibrosis via modulation of TGF-β1/Smad signaling and inflammation

Key Points

Key points are not available for this paper at this time.

Abstract

Carvacrol maintained the renal antioxidant defense, interfered with the EMT and TGF-β1/Smad signaling axis, and impeded the inflammatory response in the obstructed kidneys.

Demander à l'IA

Bookmark

Cite This Study

Ram et al. (Sat,) studied this question.

synapsesocial.com/papers/69dd3fc199c691022d99b8d9 https://doi.org/https://doi.org/10.1039/d2fo01384c

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Polysaccharides extracted from <i>balanophora polyandra Griff</i> (BPP) ameliorate renal Fibrosis and EMT via inhibiting the Hedgehog pathway2021 · 29 citations
2State of the Care, Definition, and Epidemiology of Chronic Kidney Disease2021 · 2 citations
3Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20172020 · 6,631 citations
4TGF-β: the master regulator of fibrosis2016 · 3,477 citations
5Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway2021 · 58 citations

Demander à l'IA

Bookmark